MECFS Canterbury
Financial Assistance from Work and Income when we are chronically ill
There is a slide deck linked to in the description of the videoIs there a transcript or slideshow version?
Not just the doctors not taking them seriouslynewsroom said:Between 6 percent and10 percent of those who get Covid-19 end up with symptoms that persist beyond the period of acute illness. Sometimes these symptoms are minor. Sometimes they diminish or disappear completely, in time. Often, they are grievous and chronic.
The Long Covid Registry follows another nationwide study into the impact of Covid-19 in New Zealand. That project sought to interview everyone infected before the Omicron wave. About 10 percent of that population was reached, in the end, and 22 percent of those met the World Health Organisation classification for Long Covid. They reported stigmatisation, a lack of financial support, and trouble even getting their doctors to take them seriously.
newsroom said:In December, Newsroom reported that the Treasury, the Department of Prime Minister and Cabinet, the Ministry for Social Development and the Ministry of Business, Innovation and Employment had not done any work to discern the potential impacts of the illness on the economy or any other aspect of New Zealand society. The health and education ministries had also not undertaken any work on the impact on their respective workforces.
https://newsroom.co.nz/2023/11/17/this-isnt-a-life-the-crushing-burden-of-long-covid/newsroom said:Since then, a summer intern at the Treasury did estimate that Long Covid cost the New Zealand economy $140 million in 2022, though this doesn’t represent a formal Treasury finding.
Sean O'Neill and his daughter Maeve Boothby-O'Neill Photo: supplied
The programme has two quite separate sections:https://www.rnz.co.nz/national/prog...ted-and-isolated-living-and-dying-with-me-cfs
HEALTH
9:29 am today
Unsupported and isolated: living and dying with ME/CFS
From Saturday Morning, 9:29 am today
Paywalled
https://www.nzdoctor.co.nz/article/...in-chronic-fatigue-syndrome-and-its-treatment
Polyvagal theory may explain chronic fatigue syndrome and its treatment
13 December 2023
![]()
Bruce Arroll
Wednesday 13 December 2023
Polyvagal theory! That's not even a proper hypothesis, let alone a theory. And the author of that "CFS explanation" is responsible for a good chunk of medical education in NZ (he's also a vigorous promoter of the Lightning Process). Just saying. And the RNZCGP endorses opining about polyvagal "theory" for CME creditsNZ Doctor article said:This article looks at the effective treatments for chronic fatigue syndrome and why the polyvagal theory explains CFS quite well. This Practice article has been endorsed by the RNZCGP and has been approved for up to 0.25 credits for continuing professional...
2022 NZ Doctor article said:Does polyvagal theory have any application in general practice?
https://www.nzdoctor.co.nz/article/...-theory-have-any-application-general-practice (paywall)2022 NZ Doctor article said:This article looks at polyvagal theory and how it can help patients presenting to primary care with physical symptoms relating to stress Key points , Polyvagal theory is organised around a hierarchical “autonomic ladder” with three discrete levels: ventral vagal, sympathetic and ...
Additionally, a major limitation of the polyvagal conjectures, and in fact, all psychophysiological theorizing about the vagus and the psyche is the fact that there is, effectively, only one noninvasive and nonintrusive index of vagal activity, respiratory sinus arrhythmia (RSA), and that measure is only an imperfect and indirect marker of vagally mediated control of heart rate — but of no other vagally mediated processes [...] Nevertheless, RSA is the linchpin for almost all psychophysiological speculations regarding the parasympathetic system, and this is very true for polyvagal hypotheses.
There is broad consensus among experts specialized in the vertebrate evolution of the autonomic nervous system, vertebrate evolution of sociality and neuroanatomy of the brainstem and the vagus nerve that each basic physiological assumption of the polyvagal theory is untenable.
https://www.rnz.co.nz/news/national/505645/life-with-long-covid-what-it-s-really-likeLiving with Long Covid can be exhausting, painful and lonely, and most people do not know when their symptoms will improve.
More than 2000 people in New Zealand have registered as having Long Covid, while another 1200 have started the process to join the official registry.
It was set up by University of Auckland researchers to get a better understanding of how many people in New Zealand have the disease.
Those academics think around 10 to 20 percent of people infected by Covid-19 may go on to develop Long Covid, which means up to 200,000 could be suffering.
Every person with Long Covid has a story - here are a few to show what life with the disease can be like
...
Links between Chronic Fatigue Syndrome and Long Covid found
https://www.rnz.co.nz/national/prog...chronic-fatigue-syndrome-and-long-covid-found
Similar pieces also turned up on Newtalk ZB (interview) and in the NZ Doctor (article)"Dunedin researchers reveal strong link between #longCOVID & #chronicfatiguesyndrome"
https://www.newshub.co.nz/home/new-...-long-covid-and-chronic-fatigue-syndrome.html
Yes, that was a bit garbled. Hopefully the damage was limited, most people have no idea what behavioural therapies are and might remember the sciencey lab setting instead. Fortunately Tate expressed himself better in the NZ DoctorWatched this on Newshub last night. I am very disappointed with Prof Tate using the term Chronic Fatigue Syndrome. I agree ME/LC should have designated public clinics like in diabetic care - but not with all the rubbish he said has helped people including the dubious nutriceuticals and even worse - behavioural therapy.
NZ Doctor said:Therapeutic targeting of the immune response/inflammatory pathways could be effective, Emeritus Professor Tate says.
“Currently, patients with ME/CFS and Long COVID will understandably clutch at any potential treatment suggested to find a better quality of life in the absence of defined treatments.
“That means often multiple drugs, nutraceuticals, cognitive therapies and relaxation strategies with possible crossover adverse effects are being tried at the same time, without resulting benefit to the patient in most cases.”
While potential compounds are available that target different points of the cellular energy production pathway, no systematic studies have been carried out to determine whether they show real benefit.
https://www.1news.co.nz/2024/01/28/...-woman-helping-others-with-similar-condition/For a large part of the past three decades, Wendy Mathews has been in bed, and continuously for eight years.
“I don’t really get out of it, I’m here 24/7.”
She has myalgic encephalomyelitis (ME), a neuro-inflammatory disease that causes profound fatigue unaffected by rest.
But while Wendy is bed-ridden, she isn’t idle.
“Everything I have or need to do, I have to do here in bed.”
In 2017, Wendy created a charity called Rest Assured. It offers food deliveries, support, and comfort to those stuck at home with ME, chronic fatigue syndrome, or fibromyalgia.
[continues at link]
https://anzmes.org.nz/anzmes-a-globalvoiceforme-on-world-me-day-2024/As we approach World ME Day on May 12th, 2024, ANZMES joins the global community in shedding light on the pressing issues surrounding Myalgic Encephalomyelitis (ME). This significant day coincides with the 55th anniversary since the World Health Organization (WHO) officially acknowledged ME in their International Classification of Diseases, underscoring the critical need to address this global health crisis.
In recent times, the landscape of ME has undergone a transformation, with COVID-19 emerging as the most common trigger for this chronic illness. The intersection of these two health challenges has resulted in a significant increase in the number of people affected by ME. Today, we estimate that at least 55 million individuals worldwide are living with the debilitating effects of this condition. Amidst these escalating numbers, ANZMES proudly stands alongside World ME Alliance members across the globe, collectively amplifying support for initiatives that seek to address the multifaceted impact of ME on individuals and communities alike.
No Cure, No Universal Treatment
One of the harsh realities we face is that there is currently no cure for ME, nor universally effective treatments. Individuals grappling with ME often endure not only the physical toll of the illness but also the stigmas that accompany it. It is imperative that we, as a global community, come together to address these gaps in understanding, research and treatment.
[...]